We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » FDA Updates COVID-19 Guidance to Address Remote Data Monitoring in Trials
FDA Updates COVID-19 Guidance to Address Remote Data Monitoring in Trials
The FDA has updated its guidance on conducting clinical trials during the COVID-19 pandemic, advising sponsors to use a risk assessment to see if they need to re-monitor remotely monitored data using in-person site visits after pandemic restrictions are lifted.